Investigative Ophthalmology & Visual Science, Vol 39, 840-845, Copyright © 1998 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Abnormal panretinal response pattern to carbogen inhalation in experimental retinopathy of prematurity

BA Berkowitz and JS Penn
Department of Anatomy and Cell Biology, Wayne State University, Detroit, Michigan 48201, USA.

PURPOSE: Present technologies are not able to determine which retinas are at risk for the development of neovascularization in retinopathy of prematurity (ROP). In this study, the authors evaluated whether a novel magnetic resonance imaging (MRI) method could be used to identify differences between control retinas and those that will develop neovascularization in the newborn rat model of retinopathy of prematurity (ROP). METHODS: MRI and a 2-minute carbogen (95% O2/5% CO2) inhalation challenge (see ref. 11) were used to measure noninvasively the change in the posterior vitreous oxygen tension in specific locations across the full extent of the retina in day-12 rats raised in either room air (control, n = 7) or variable oxygen conditions (experimental ROP, n = 7). The experimental ROP animals were examined 2 days before the onset of neovascularization. RESULTS: In the ROP group, the response to carbogen was lower (P < 0.05) at every distance from the optic nerve than in the control group. Within the ROP group, the vascular midperipheral retinal reaction to carbogen, 1 to 2 mm from the optic nerve, was as low as that from the avascular periphery, 2 to 3 mm from the optic nerve. Although the vascular central retinal response to carbogen, 0 to 1 mm from the optic nerve, was greater than either the vascular midperipheral retina or the avascular periphery in the ROP group, theoretically this difference could be caused by oxygen diffusing from the hyaloidal circulation. CONCLUSIONS: Carbogen- challenge MRI seems to be a useful tool for assessing the risk of retinal neovascularization in the newborn rat ROP model. This MRI method has potential clinical applicability, for example, because effective laser therapy with retinal sparing may be possible if focal photocoagulation, guided by an MRI map, is performed.

This article has been cited by other articles:

				B. A. Berkowitz, R. Roberts, J. S. Penn, and M. Gradianu High-Resolution Manganese-Enhanced MRI of Experimental Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4733 - 4740. [Abstract] [Full Text] [PDF]

				G. L. Trick, P. Edwards, U. Desai, and B. A. Berkowitz Early supernormal retinal oxygenation response in patients with diabetes. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1612 - 1619. [Abstract] [Full Text] [PDF]

				H. Luan, M. Leitges, R. R. Gupta, D. Pacheco, A. Seidner, J. Liggett, Y. Ito, R. Kowluru, and B. A. Berkowitz Effect of PKC{beta} on Retinal Oxygenation Response in Experimental Diabetes Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 937 - 942. [Abstract] [Full Text] [PDF]

				R. Roberts, W. Zhang, Y. Ito, and B. A. Berkowitz Spatial Pattern and Temporal Evolution of Retinal Oxygenation Response in Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5315 - 5320. [Abstract] [Full Text] [PDF]

				W. Zhang, Y. Ito, E. Berlin, R. Roberts, H. Luan, and B. A. Berkowitz Specificity of Subnormal {Delta}PO2 for Retinal Neovascularization in Experimental Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3551 - 3555. [Abstract] [Full Text] [PDF]

				W. Zhang, Y. Ito, E. Berlin, R. Roberts, and B. A. Berkowitz Role of Hypoxia during Normal Retinal Vessel Development and in Experimental Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3119 - 3123. [Abstract] [Full Text] [PDF]

				N. D. Wangsa-Wirawan and R. A. Linsenmeier Retinal Oxygen: Fundamental and Clinical Aspects Arch Ophthalmol, April 1, 2003; 121(4): 547 - 557. [Abstract] [Full Text] [PDF]

				O. Dembinska, L. M. Rojas, S. Chemtob, and P. Lachapelle Evidence for a Brief Period of Enhanced Oxygen Susceptibility in the Rat Model of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2481 - 2490. [Abstract] [Full Text] [PDF]

				B. A. Berkowitz, Y. Ito, T. S. Kern, C. McDonald, and R. Hawkins Correction of Early Subnormal Superior Hemiretinal {Delta}PO2 Predicts Therapeutic Efficacy in Experimental Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2964 - 2969. [Abstract] [Full Text] [PDF]

				J. S. Penn, V. S. Rajaratnam, R. J. Collier, and A. F. Clark The Effect of an Angiostatic Steroid on Neovascularization in a Rat Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 283 - 290. [Abstract] [Full Text]

				P. Hardy, I. Dumont, M. Bhattacharya, X. Hou, P. Lachapelle, D. R. Varma, and S. Chemtob Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy Cardiovasc Res, August 18, 2000; 47(3): 489 - 509. [Abstract] [Full Text] [PDF]

				A. Shafiee, J. S. Penn, H. C. Krutzsch, J. K. Inman, D. D. Roberts, and D. A. Blake Inhibition of Retinal Angiogenesis by Peptides Derived from Thrombospondin-1 Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2378 - 2388. [Abstract] [Full Text]

				B. A. Berkowitz and W. Zhang Significant Reduction of the Panretinal Oxygenation Response after 28% Supplemental Oxygen Recovery in Experimental ROP Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1925 - 1931. [Abstract] [Full Text]

				S. Zhang, D. A. Leske, and J. M. Holmes Neovascularization Grading Methods in a Rat Model of Retinopathy of Prematurity Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 887 - 891. [Abstract] [Full Text]

				B. A. Berkowitz, R. A. Kowluru, R. N. Frank, T. S. Kern, T. C. Hohman, and M. Prakash Subnormal Retinal Oxygenation Response Precedes Diabetic-like Retinopathy Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 2100 - 2105. [Abstract] [Full Text] [PDF]